Sarangan, Rayna S.

HRN: 24-01-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/30/2023
11/06/2023
IV
1.5g
Q6h
Infected Wound
Waiting Final Action 
10/30/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/30/2023
11/06/2023
IV
600mg
Q6h
Infected Wound
Waiting Final Action 
10/30/2023
CEFTAZIDIME 1GM (VIAL)
10/31/2023
11/06/2023
IV
2gm
Q8H
Infected Wound
Waiting Final Action 
11/04/2023
MUPIROCIN 2%, 15G (TUBE)
11/04/2023
11/11/2023
TOPICAL
2%
BID
Infected Wound Lateral Neck
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: